Hyundai Bioscience Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 20.53%

Hyundai Bioscience Co. Ltd (048410) has an Asset Resilience Ratio of 20.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 048410 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩23.94 Billion

≈ $16.22 Million USD Cash + Short-term Investments

Total Assets

₩116.62 Billion

≈ $79.03 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2023)

This chart shows how Hyundai Bioscience Co. Ltd's Asset Resilience Ratio has changed over time. See Hyundai Bioscience Co. Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Hyundai Bioscience Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Hyundai Bioscience Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩23.94 Billion	20.53%
Total Liquid Assets	₩23.94 Billion	20.53%

Asset Resilience Insights

Good Liquidity Position: Hyundai Bioscience Co. Ltd maintains a healthy 20.53% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Hyundai Bioscience Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Hyundai Bioscience Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Hyundai Bioscience Co. Ltd (2002–2023)

The table below shows the annual Asset Resilience Ratio data for Hyundai Bioscience Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	18.94%	₩10.00 Billion ≈ $6.78 Million	₩52.79 Billion ≈ $35.78 Million	-8.88pp
2022-12-31	27.82%	₩18.73 Billion ≈ $12.69 Million	₩67.33 Billion ≈ $45.63 Million	+0.26pp
2021-12-31	27.57%	₩22.20 Billion ≈ $15.04 Million	₩80.53 Billion ≈ $54.57 Million	+6.76pp
2020-12-31	20.81%	₩19.21 Billion ≈ $13.02 Million	₩92.31 Billion ≈ $62.56 Million	+9.65pp
2019-12-31	11.16%	₩7.06 Billion ≈ $4.78 Million	₩63.24 Billion ≈ $42.85 Million	+5.30pp
2018-12-31	5.85%	₩3.16 Billion ≈ $2.14 Million	₩54.01 Billion ≈ $36.60 Million	-9.32pp
2017-12-31	15.17%	₩7.51 Billion ≈ $5.09 Million	₩49.50 Billion ≈ $33.54 Million	-8.69pp
2016-12-31	23.86%	₩12.74 Billion ≈ $8.63 Million	₩53.38 Billion ≈ $36.18 Million	+21.76pp
2015-12-31	2.10%	₩910.00 Million ≈ $616.69K	₩43.41 Billion ≈ $29.42 Million	-0.68pp
2014-12-31	2.77%	₩910.00 Million ≈ $616.69K	₩32.81 Billion ≈ $22.23 Million	+2.32pp
2013-12-31	0.45%	₩140.09 Million ≈ $94.94K	₩30.84 Billion ≈ $20.90 Million	+0.45pp
2012-12-31	0.00%	₩66.00K ≈ $44.73	₩32.06 Billion ≈ $21.73 Million	-5.43pp
2011-12-31	5.43%	₩1.65 Billion ≈ $1.12 Million	₩30.47 Billion ≈ $20.65 Million	+5.11pp
2010-12-31	0.32%	₩154.50 Million ≈ $104.71K	₩48.45 Billion ≈ $32.83 Million	-4.12pp
2009-12-31	4.43%	₩2.71 Billion ≈ $1.84 Million	₩61.19 Billion ≈ $41.46 Million	+0.43pp
2008-12-31	4.01%	₩3.51 Billion ≈ $2.38 Million	₩87.53 Billion ≈ $59.31 Million	-13.64pp
2007-12-31	17.65%	₩18.21 Billion ≈ $12.34 Million	₩103.16 Billion ≈ $69.91 Million	+15.06pp
2006-12-31	2.58%	₩2.73 Billion ≈ $1.85 Million	₩105.52 Billion ≈ $71.51 Million	-15.58pp
2005-12-31	18.16%	₩41.93 Billion ≈ $28.41 Million	₩230.83 Billion ≈ $156.43 Million	+3.53pp
2004-12-31	14.64%	₩32.91 Billion ≈ $22.30 Million	₩224.80 Billion ≈ $152.34 Million	+1.80pp
2003-12-31	12.84%	₩31.14 Billion ≈ $21.10 Million	₩242.55 Billion ≈ $164.37 Million	-4.91pp
2002-12-31	17.74%	₩35.59 Billion ≈ $24.12 Million	₩200.60 Billion ≈ $135.94 Million	--

pp = percentage points

About Hyundai Bioscience Co. Ltd

KQ:048410 Korea Biotechnology

Market Cap

$872.13 Million

₩1.29 Trillion KRW

Market Cap Rank

#9737 Global

#279 in Korea

Share Price

₩13400.00

Change (1 day)

-8.22%

52-Week Range

₩4595.00 - ₩20000.00

All Time High

₩54700.00